Inventor
Vivek Rauniyar
Inventor
Cambridge, MA, US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes30%
PatentTitleYear
10,660,888Aminoheteroaryl benzamides as kinase inhibitors202010,377,770Tricyclic compounds and compositions as kinase inhibitors201910,188,649Aminoheteroaryl benzamides as kinase inhibitors201910,167,279Compounds and compositions as RAF kinase inhibitors20199,763,937'Aminoheteroaryl benzamides as kinase inhibitors'20179,546,173'Substituted pyrrolo[3,4-d]pyrimidines as kinase inhibitors'20179,242,996'Aminoheteroaryl benzamides as kinase inhibitors'2016Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2016–2020Patents assigned to NOVARTIS AG (7)· patent assignee history
2016–2017Patents assigned to LINDVALL MIKA (3)· patent assignee history
2016–2017Patents assigned to POON DANIEL (3)· patent assignee history
2016–2017Patents assigned to RAUNIYAR VIVEK (3)· patent assignee history
2016–2017Patents assigned to BAGDANOFF JEFFREY T (2)· patent assignee history
2016–2020Based in Cambridge, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 7 | 2016–2020 |
| LINDVALL MIKA | 3 | 2016–2017 |
| POON DANIEL | 3 | 2016–2017 |
| RAUNIYAR VIVEKself | 3 | 2016–2017 |
| BAGDANOFF JEFFREY T | 2 | 2016–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Cambridge, Massachusetts, US | 7 | 2016–2020 |